Can-Fite Biopharma Price Target Raised to $8.00/Share From $5.00 by HC Wainwright & Co.
DO Dow Jones Newswires Can-Fite Biopharma Price Target Raised to $8.00/Share From $5.00 by HC Wainwright & Co. 7/2/2026, 07:09 PM GMT+8 Dow Jones Newswires CA CANF Can-Fite Biopharma Price Target Raised to $8.00/Share From $5.00 by HC Wainwright & Co. Market News Stocktwits Why Is CANF Stock Surging Today? GlobeNewswire Can-Fite Phase 2a Pancreatic Cancer Study with Namodenoson Achieves Primary Safety Endpoint and Demonstrates Durable Survival Outcomes in Advanced Disease
